Granite Investment Partners’s Abiomed Inc ABMD Stock Holding History

Granite Investment Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-61,802	Closed	-$5.86M	–	311
2016 Q1	$5.86M	Sell	61,802 -46,802	-43%	-$3.95M	0.53%	68
2015 Q4	$9.8M	Buy	108,604 +33,707	+45%	+$2.86M	0.89%	19
2015 Q3	$6.95M	Buy	74,897 +42,819	+133%	+$3.77M	0.67%	50
2015 Q2	$2.11M	Sell	32,078 -12,987	-29%	-$863K	0.19%	148
2015 Q1	$3.23M	Sell	45,065 -11,115	-20%	-$603K	0.28%	124
2014 Q4	$2.14M	Sell	56,180 -1,420	-2%	-$44.8K	0.24%	146
2014 Q3	$1.43M	Sell	57,600 -19,996	-26%	-$506K	0.2%	155
2014 Q2	$1.95M	Sell	77,596 -4,582	-6%	-$107K	0.28%	90
2014 Q1	$2.14M	Sell	82,178 -1,709	-2%	-$47.3K	0.33%	81
2013 Q4	$2.24M	Buy	+83,887	New	+$2.07M	0.34%	83

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Granite Investment Partners's ABMD Position: Q2 2016 in Review

Granite Investment Partners sold out of Abiomed Inc (ABMD) in Q2 2016, closing a stake of 61,802 shares — an estimated $5.86M sold.

Granite Investment Partners first reported a position in ABMD in Q4 2013 and held it in 10 quarters. The position peaked at $9.8M in Q4 2015. 297 funds tracked by Wall St. Rank hold ABMD as of Q2 2016.

Granite Investment Partners reported no remaining Abiomed Inc position as of Q2 2016 after selling out during the quarter.
Granite Investment Partners sold 61,802 Abiomed Inc shares in Q2 2016, an estimated $5.86M.
Granite Investment Partners first reported a position in Abiomed Inc in Q4 2013 and held it in 10 quarters.
Granite Investment Partners's Abiomed Inc position peaked at $9.8M in Q4 2015.
297 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2016.

Based on Granite Investment Partners's 13F filing for Q2 2016, filed 15 Aug 2016.